PT801575E - Vectores retrovirais para expressao em celulas embrionarias - Google Patents

Vectores retrovirais para expressao em celulas embrionarias

Info

Publication number
PT801575E
PT801575E PT95944182T PT95944182T PT801575E PT 801575 E PT801575 E PT 801575E PT 95944182 T PT95944182 T PT 95944182T PT 95944182 T PT95944182 T PT 95944182T PT 801575 E PT801575 E PT 801575E
Authority
PT
Portugal
Prior art keywords
vector
retroviral
embryonic cells
expression
virus
Prior art date
Application number
PT95944182T
Other languages
English (en)
Inventor
Donald B Kohn
Pia M Challita
Original Assignee
Los Angeles Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Angeles Childrens Hospital filed Critical Los Angeles Childrens Hospital
Publication of PT801575E publication Critical patent/PT801575E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT95944182T 1994-12-21 1995-12-19 Vectores retrovirais para expressao em celulas embrionarias PT801575E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/361,112 US5707865A (en) 1994-12-21 1994-12-21 Retroviral vectors for expression in embryonic cells

Publications (1)

Publication Number Publication Date
PT801575E true PT801575E (pt) 2006-08-31

Family

ID=23420695

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95944182T PT801575E (pt) 1994-12-21 1995-12-19 Vectores retrovirais para expressao em celulas embrionarias

Country Status (11)

Country Link
US (1) US5707865A (pt)
EP (1) EP0801575B1 (pt)
JP (1) JPH10510995A (pt)
AT (1) ATE323776T1 (pt)
AU (1) AU693317B2 (pt)
CA (1) CA2208210A1 (pt)
DE (1) DE69534948T2 (pt)
DK (1) DK0801575T3 (pt)
NZ (1) NZ300795A (pt)
PT (1) PT801575E (pt)
WO (1) WO1996019245A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5703796A (en) * 1995-05-10 1996-11-29 Introgene B.V. Improved retroviral vectors, especially suitable for gene th erapy
JP3877769B2 (ja) * 1995-06-02 2007-02-07 湧永製薬株式会社 組み換えレトロウイルス産生細胞
US7129043B1 (en) * 1998-10-22 2006-10-31 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6534300B1 (en) * 1999-09-14 2003-03-18 Genzyme Glycobiology Research Institute, Inc. Methods for producing highly phosphorylated lysosomal hydrolases
EP2060582A1 (en) 2001-05-31 2009-05-20 Novartis Ag Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20040009158A1 (en) * 2002-07-11 2004-01-15 Washington University Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
CN106794262A (zh) 2014-07-31 2017-05-31 俄克拉何马大学董事会 哺乳动物rpe65的高异构水解酶活性突变体
CN110607394A (zh) * 2018-06-15 2019-12-24 云舟生物科技（广州）有限公司 莫洛尼鼠白血病病毒滴度检测试剂盒及滴度检测方法

Also Published As

Publication number Publication date
ATE323776T1 (de) 2006-05-15
EP0801575A1 (en) 1997-10-22
EP0801575A4 (en) 2001-08-16
DE69534948D1 (de) 2006-05-24
CA2208210A1 (en) 1996-06-27
NZ300795A (en) 2001-08-31
WO1996019245A1 (en) 1996-06-27
US5707865A (en) 1998-01-13
EP0801575B1 (en) 2006-04-19
DK0801575T3 (da) 2006-08-21
AU693317B2 (en) 1998-06-25
DE69534948T2 (de) 2006-11-16
JPH10510995A (ja) 1998-10-27
AU4604696A (en) 1996-07-10

Similar Documents

Publication Publication Date Title
GB2331522A (en) Lentiviral vectors
PT801575E (pt) Vectores retrovirais para expressao em celulas embrionarias
Wimmer et al. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b
GB2325003A (en) Rectroviral vectors
CY1107760T1 (el) Κυτταρα φακοϊικου εγκλεισμου
DE69619514T2 (de) Retrovirale vektoren
JP2003514565A5 (pt)
DK0975783T3 (da) Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
ES8900170A1 (es) Procedimiento de modificacion de celulas eucariotas.
NO983375L (no) Retroviral vektor og anvendelse derav i genterapi
AU3693689A (en) Compositions having use as treatment of psoriasis and neuropsychiatric deficits
WO2002034929A3 (en) Expression vectors and uses thereof
CA2199131A1 (en) Retroviral vector hybrids and the use thereof for gene transfer